These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10452100)

  • 1. Pharmacokinetics and peripheral platelet counts after a single dose of recombinant human thrombopoietin in rhesus monkeys.
    Song HF; Liu XW; Tang ZM
    Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):244-8. PubMed ID: 10452100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study.
    Wolff SN; Herzig R; Lynch J; Ericson SG; Greer JP; Stein R; Goodman S; Benyunes MC; Ashby M; Jones DV; Fay J
    Bone Marrow Transplant; 2001 Feb; 27(3):261-8. PubMed ID: 11277173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical tolerance test of recombinant human thrombopoietin].
    Zhao Y; Jiang J; Jiao L
    Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1508-11. PubMed ID: 16200777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and hematological effects of the PEGylated thrombopoietin peptide mimetic GW395058 in rats and monkeys after intravenous or subcutaneous administration.
    de Serres M; Yeager RL; Dillberger JE; Lalonde G; Gardner GH; Rubens CA; Simkins AH; Sailstad JM; McNulty MJ; Woolley JL
    Stem Cells; 1999; 17(6):316-26. PubMed ID: 10606160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
    Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of His-tag recombinant human endostatin in Rhesus monkeys.
    Song HF; Liu XW; Zhang HN; Zhu BZ; Yuan SJ; Liu SY; Tang ZM
    Acta Pharmacol Sin; 2005 Jan; 26(1):124-8. PubMed ID: 15659125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia.
    Vadhan-Raj S; Patel S; Bueso-Ramos C; Folloder J; Papadopolous N; Burgess A; Broemeling LD; Broxmeyer HE; Benjamin RS
    J Clin Oncol; 2003 Aug; 21(16):3158-67. PubMed ID: 12915607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and partial thromboplastin time after intravenous recombinant hirudin variant-2 in rhesus monkeys.
    Liu XW; Song HF; Tang ZM; Zhao K; Zhu BZ; Wang LP; Zhang Y
    Acta Pharmacol Sin; 2002 Sep; 23(9):842-6. PubMed ID: 12230955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A multi-center clinical trial of recombinant human thrombopoietin in chronic refractory idiopathic thrombocytopenic purpura].
    Zhao YQ; Wang QY; Zhai M; Xu J; Chen XQ; Liu WL; Zhang M; Song SJ; Wang JM; Meng FY; Shan YD
    Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):608-10. PubMed ID: 15355668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis.
    Wang Y; Wang Z; Wu L; Zhang J; Wang J; Yan L
    Ann Hematol; 2013 Dec; 92(12):1695-9. PubMed ID: 23778995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.
    Nash RA; Kurzrock R; DiPersio J; Vose J; Linker C; Maharaj D; Nademanee AP; Negrin R; Nimer S; Shulman H; Ashby M; Jones D; Appelbaum FR; Champlin R
    Biol Blood Marrow Transplant; 2000; 6(1):25-34. PubMed ID: 10707996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: low-dose TBI does not prevent sensitization.
    Nash RA; Takatu A; Feng Z; Slichter S; Abrams K; Espino G; Gass MJ; Georges GE; McSweeney PA; Shulman HM; Storb R
    Biol Blood Marrow Transplant; 2002; 8(7):360-7. PubMed ID: 12171482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys.
    Sola MC; Christensen RD; Hutson AD; Tarantal AF
    Pediatr Res; 2000 Feb; 47(2):208-14. PubMed ID: 10674348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study.
    Liu X; Bai Y; Wang T; Song Y; Sun F; Xia R; Zhu F; Ma J; Lu Q; Ye X; Zhan X; Li L; Guo X; Cheng S; Li Y; Guo Z; Chen Y; Qian S; Qin L; Zhang Q; Cao S; Yang R
    Platelets; 2023 Dec; 34(1):2157806. PubMed ID: 36597010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic Effect of Single Intramuscular Administration of Recombinant Human Thrombopoietin on Rhesus Monkeys with Acute radiation Sickness].
    Yang JK; Xing S; Shen X; Wang X; Jiang Y; Zhang XW; Luan H; Qiao ZZ; Dai YY; Zhang EQ; Wang YM; Xiong GL; Yu ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1887-1892. PubMed ID: 36476921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic modeling of pegylated thrombopoietin mimetic peptide (PEG-TPOm) after single intravenous dose administration in healthy subjects.
    Samtani MN; Perez-Ruixo JJ; Brown KH; Cerneus D; Molloy CJ
    J Clin Pharmacol; 2009 Mar; 49(3):336-50. PubMed ID: 19246731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of thrombopoietin II on exsanguine thrombocytopenia mouse death rate].
    Chen Y; Zhong L; Zhong X
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):379-81. PubMed ID: 11810766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human thrombopoietin improves platelet counts and reduces platelet transfusion possibility among patients with severe sepsis and thrombocytopenia: a prospective study.
    Wu Q; Ren J; Wu X; Wang G; Gu G; Liu S; Wu Y; Hu D; Zhao Y; Li J
    J Crit Care; 2014 Jun; 29(3):362-6. PubMed ID: 24405656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.